These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1514138)

  • 1. [Plasma cell leukemia. Study of 6 patients].
    Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
    Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma cell leukemia. Study of 10 cases].
    López Guillermo A; Martí JM; Bladé J; Nomdedeu B; Montserrat E; Rozman C
    Sangre (Barc); 1989 Feb; 34(1):28-31. PubMed ID: 2652343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma cell leukemia: our experience in 4 cases].
    Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
    Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell leukemia. A report on 11 patients and review of the literature.
    Pasqualetti P; Festuccia V; Collacciani A; Acitelli P; Casale R
    Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
    Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
    Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
    Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
    Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary plasma cell leukemia occuring in the young.
    Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
    Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma cell leukemia].
    Egli F; Rhyner K
    Schweiz Rundsch Med Prax; 1989 Jan; 78(3):29-34. PubMed ID: 2919252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
    Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
    Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
    Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
    Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
    Peijing Q; Yan X; Yafei W; Dehui Z; Zengjun L; Junyuan Q; Yaozhong Z; Lugui Q
    Acta Haematol; 2009; 121(1):47-51. PubMed ID: 19339770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
    Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
    Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
    Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
    Klug S; Höltermann F; Fritsch H
    Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.